their guidance comes with the following statement ( which does create a little uncertainty - and we know what the market hates)
Regis maintains its guidance for FY22 as detailed in Table 4. While maintaining this guidance, Regis notes further
lockdowns in WA and across Australia, along with associated travel restrictions are causing pressures on the business,
including extending periods to fill vacancy and labour cost pressures. In addition, potential impacts of the requirement
for mandatory vaccination including personnel availability are not fully understood. The situation remains fluid and the
Company continues to monitor for potential impacts and take action where appropriate.
If they can turn performance around next qtr and hit 120+ ounces I think the market will start to feel better until then I think we may remain in limbo for a while longer or some left field good news appears.
- Forums
- ASX - By Stock
- RRL
- Ann: Quarterly Activities Report
RRL
regis resources limited
Add to My Watchlist
2.23%
!
$4.39

Ann: Quarterly Activities Report, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.39 |
Change
-0.100(2.23%) |
Mkt cap ! $3.316B |
Open | High | Low | Value | Volume |
$4.47 | $4.53 | $4.37 | $16.81M | 3.793M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 51252 | $4.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 7201 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 51252 | 4.360 |
4 | 37004 | 4.350 |
2 | 24411 | 4.340 |
2 | 6157 | 4.310 |
5 | 37325 | 4.300 |
Price($) | Vol. | No. |
---|---|---|
4.390 | 7201 | 1 |
4.400 | 28087 | 1 |
4.410 | 38340 | 4 |
4.420 | 26563 | 3 |
4.430 | 15681 | 1 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online